Conference item icon

Conference item

Autologous haematopoietic stem cell transplantation for Crohn's disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

Abstract:
Autologous haematopoietic stem cell transplantation (AHSCT) is an emerging therapeutic option for refractory Crohn’s disease (CD). The ASTIC trial of AHSCT failed to meet its stringent composite primary endpoint, but 1-year follow-up data demonstrate sustained efficacy. The real-world use and outcomes of AHSCT for CD are unknown. Using the EBMT registry, we evaluated long-term outcomes for patients (pts) undergoing AHSCT for CD in Europe.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1093/ecco-jcc/jjx180.020

Authors


Expand authors...
Publisher:
Oxford University Press Publisher's website
Volume:
12
Issue:
supplement_1
Pages:
S014–S015
Publication date:
2018-01-16
Acceptance date:
2017-12-22
DOI:
ISSN:
1873-9946 and 1876-4479
Pubs id:
pubs:844394
URN:
uri:15e4a42e-ef82-4327-bc75-2240184194dc
UUID:
uuid:15e4a42e-ef82-4327-bc75-2240184194dc
Local pid:
pubs:844394

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP